129 related articles for article (PubMed ID: 16750347)
1. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms.
Talamo A; Centorrino F; Tondo L; Dimitri A; Hennen J; Baldessarini RJ
Schizophr Res; 2006 Sep; 86(1-3):251-5. PubMed ID: 16750347
[TBL] [Abstract][Full Text] [Related]
2. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.
Potvin S; Joyal CC; Pelletier J; Stip E
Schizophr Res; 2008 Mar; 100(1-3):242-51. PubMed ID: 17614260
[TBL] [Abstract][Full Text] [Related]
3. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
Wobrock T; Falkai P; Schneider-Axmann T; Hasan A; Galderisi S; Davidson M; Kahn RS; Derks EM; Boter H; Rybakowski JK; Libiger J; Dollfus S; López-Ibor JJ; Peuskens J; Hranov LG; Gaebel W; Fleischhacker WW;
Schizophr Res; 2013 Jun; 147(1):132-139. PubMed ID: 23537477
[TBL] [Abstract][Full Text] [Related]
4. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
Zhornitsky S; Stip E; Pampoulova T; Rizkallah E; Lipp O; Bentaleb LA; Chiasson JP; Potvin S
Mov Disord; 2010 Oct; 25(13):2188-94. PubMed ID: 20669315
[TBL] [Abstract][Full Text] [Related]
5. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.
Lysaker P; Bell M; Beam-Goulet J; Milstein R
J Nerv Ment Dis; 1994 Feb; 182(2):109-12. PubMed ID: 8308528
[TBL] [Abstract][Full Text] [Related]
6. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
[TBL] [Abstract][Full Text] [Related]
7. Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia.
Jaworski F; Dubertret C; Adès J; Gorwood P
Psychiatry Res; 2011 Jan; 185(1-2):129-34. PubMed ID: 20587365
[TBL] [Abstract][Full Text] [Related]
8. [Relevance of drug use in clinical manifestations of schizophrenia].
Arias Horcajadas F; Sánchez Romero S; Padín Calo JJ
Actas Esp Psiquiatr; 2002; 30(2):65-73. PubMed ID: 12028938
[TBL] [Abstract][Full Text] [Related]
9. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
Batki SL; Leontieva L; Dimmock JA; Ploutz-Snyder R
Schizophr Res; 2008 Oct; 105(1-3):201-7. PubMed ID: 18701256
[TBL] [Abstract][Full Text] [Related]
10. Comorbid substance-use in schizophrenia: the file drawer effect, In reply to: Talamo et al., 2006. "Comorbid substance-use in schizophrenia: relation to positive and negative symptoms".
Potvin S; Sepehry AA; Stip E
Schizophr Res; 2007 Feb; 90(1-3):351-2; author reply 353-4. PubMed ID: 17055705
[No Abstract] [Full Text] [Related]
11. [Drug use and dependence in schizophrenia].
Arias Horcajadas F; Padín Calo JJ; Fernández González MA
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(6):379-89. PubMed ID: 9477606
[TBL] [Abstract][Full Text] [Related]
12. Comorbid schizophrenia and substance abuse: a review of epidemiology and course.
Westermeyer J
Am J Addict; 2006; 15(5):345-55. PubMed ID: 16966190
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
15. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
Margolese HC; Carlos Negrete J; Tempier R; Gill K
Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
[TBL] [Abstract][Full Text] [Related]
16. Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse.
Scheller-Gilkey G; Moynes K; Cooper I; Kant C; Miller AH
Schizophr Res; 2004 Aug; 69(2-3):167-74. PubMed ID: 15469190
[TBL] [Abstract][Full Text] [Related]
17. Panic symptoms in schizophrenia: comorbidity and clinical correlates.
Ulas H; Alptekin K; Akdede BB; Tumuklu M; Akvardar Y; Kitis A; Polat S
Psychiatry Clin Neurosci; 2007 Dec; 61(6):678-80. PubMed ID: 18081631
[TBL] [Abstract][Full Text] [Related]
18. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.
Margolese HC; Malchy L; Negrete JC; Tempier R; Gill K
Schizophr Res; 2004 Apr; 67(2-3):157-66. PubMed ID: 14984874
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality in schizophrenia with comorbid substance use disorders.
Lähteenvuo M; Batalla A; Luykx JJ; Mittendorfer-Rutz E; Tanskanen A; Tiihonen J; Taipale H
Acta Psychiatr Scand; 2021 Jul; 144(1):42-49. PubMed ID: 33650123
[TBL] [Abstract][Full Text] [Related]
20. Executive function in schizophrenia: influence of substance use disorder history.
Rodriguez-Jimenez R; Bagney A; Martinez-Gras I; Ponce G; Sanchez-Morla EM; Aragües M; Rubio G; Jimenez-Arriero MA; Santos JL; Palomo T;
Schizophr Res; 2010 May; 118(1-3):34-40. PubMed ID: 19854622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
